Issue 14, 2014

Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids

Abstract

In this study the potential for anticancer activity of 4-aminoquinoline-triazine based hybrids has been investigated on 60 human cancer cell lines (NCI 60). The representative compounds show activity on a range of cell lines and apoptosis as the mode of growth inhibition.

Graphical abstract: Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids

Supplementary files

Article information

Article type
Paper
Submitted
25 Sep 2013
Accepted
21 Nov 2013
First published
25 Nov 2013

RSC Adv., 2014,4, 7062-7067

Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids

S. Manohar, A. Pepe, C. E. Vélez Gerena, B. Zayas, S. V. Malhotra and D. S. Rawat, RSC Adv., 2014, 4, 7062 DOI: 10.1039/C3RA45333B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements